Introduction
Special Emphasis Pathway in Cancer Biology L41-5196
This course is designed to present pre and post doctoral trainees with an organized educational format to explore major contemporary topics in cancer biology. The elective will provide an integrated view of cancer research including basic science, translational science and clinical investigation. Approximately 60 minutes will be devoted to a didactic presentation by a faculty member with interaction by the participants. The remaining 30 minutes will be used to discuss a pivotal research paper from this field, preselected by the faculty member. Outside reading will be required (30-60 minutes per week).
Schedule and Location
- Tuesday, Noon-1:30 PM
- Mid Campus Center, 11th Floor, Main Conference Room (unless otherwise indicated)
Archive by Academic year
Date | Speaker | Title |
---|---|---|
Jan 9, 2024 | Kickoff Luncheon: Overview and Presentations | |
Jan 16, 2024 | Lee Ratner MD, PhD | Introduction and Overview |
Jan 23, 2024 | Bettina Drake, PhD, MPH | Community Approaches to Cancer Prevention |
Jan 30, 2024 | Abby Green, MD | Mutagenic Processes in Cancer |
Feb 6, 2024 | John Krais, PhD | BRCA1, DNA Damage and Cancer |
Feb 13, 2024 | Kelly Bolton, MD, PhD | BRCA1, DNA Damage and Cancer |
Feb 20, 2024 | Helen McNeill, PhD | Fat and Hippo and Cancer |
Feb 27, 2024 | David Chen, PhD | Melanoma Genetics |
Mar 5, 2023 | Sid Puram, MD, PhD | Head and Neck Cancer Immunotherapy |
Mar 12, 2024 | Spring Break | |
Mar 19, 2024 | 2nd Year CBP Trainee Presentations •Alexander Chen, PhD •Jerome Prusa, PhD •Ilah Bok, PhD (1st Year Trainee) •Pei-Yu Chen •Taylor Malachowski | •Leveraging human iPSCs to define cells of origin in pediatric low grade gliomas •Yeast Probiotic Delivered Immune Checkpoint Inhibitors Alter the Murine Gut •KEAP1 Cysteine Modifications andKEAP1 Cysteine Modifications and Proximity Interaction Network •Investigating the role of ARIDs, subunits of SWI/SNF chromatin remodeling complex, in melanoma •The role of senescent cells in chemotherapy-induced peripheral neuropathy |
Mar 26, 2024 | Yoona Kang, PhD | Myeloid Differentiation and Transformation |
Apr 2, 2024 | David Spencer, PhD | Genetics and Epigenomics of AML |
Apr 9, 2024 | Matthew Ciorba, MD | Intestinal Inflammation and Cancer |
Apr 16, 2024 | Patricia Ribeiro-Pereira, PhD | Multimodal Imaging of Cancer |
Apr 23, 2024 | Stephanie Markovina, MD, PhD | Biomarkers for Prognosis and Response to Radiation Therapy |
Apr 30, 2024 | Carmen Bergom, MD, PhD | Preclinical Models of Radiation Therapy |
Date | Speaker | Title |
---|---|---|
Jan 10, 2023 | Kickoff Luncheon: Overview and Presentations | |
Jan 17, 2023 | Jeff Magee, MD, PhD | Introduction and Overview of Pediatric Oncology |
Jan 24, 2023 | Grant Challen, PhD | Epigenetic Regulation of Normal and Malignant Hematopoiesis |
Jan 31, 2023 | Kelly Bolton, MD, PhD | Genetic and Environmental Determinates of Cancer: Lessons From Clonal Hematopoiesis |
Feb 7, 2023 | Jeff Bednarski, MD, PhD | DNA Damage Signaling in B Cell Development and Leukemogenesis |
Feb 14, 2023 | Charles Kaufman, MD, PhD | Zebrafish Models of Disease |
Feb 21, 2023 | David Gutmann, MD, PhD | Cancer Neuroscience |
Feb 28, 2023 | George Souroullas, PhD | The Role of Chromatin Modifications and Accessibiltiy in Cancer |
Mar 7, 2023 | Jacqueline Payton, MD, PhD | Epigenomes and Epigenetic (De)regulation in Cancer |
Mar 14, 2023 | Spring Break | |
Mar 21, 2023 | Stephen Sykes, PhD | Cancer Metabolism |
Mar 28, 2023 | David Wilson, MD, PhD | Fanconi Anemia |
Apr 4, 2023 | Brian Van Tine, MD, PhD | Tumor Metabolism |
Apr 11, 2023 | Laura Scheuttpelz, MD, PhD | Inflammation and Hematopoietic Malignancies |
Apr 25, 2023 | Josh Rubin, MD, PhD | Sex Differences in Cancer Should Come as No Surprise |
Jun 13, 2023 | Thales Papagiannakopoulos, PhD New York University |
Date | Speaker | Title |
---|---|---|
Jan 11, 2022 | Virtual Luncheon: Annual Research-In-Progress Trainee Forum | |
Jan 18, 2022 | Lee Ratner | Introduction |
Jan 25, 2022 | Angela Mazul and Jose Zevallos | HPV Head and Neck Cancers |
Feb 1, 2022 | Cynthia Ma | CDK and Breast Cancer Biology |
Feb 8, 2022 | Stephen Oh | Myeloproliferative Neoplasms |
Feb 15, 2022 | Matthew Walter | Myelodysplastic Syndromes |
Feb 22, 2022 | Milan Chheda | Glioblastoma Overview: Diagnosis, Treatment and Clinical Challenges |
Mar 1, 2022 | Albert Kim | Glioma Stem Cells and Cell State |
Mar 8, 2022 | Tanner Johanns | Antigen Discovery and Targeting (Vaccine, CAR, etc.) |
Mar 15, 2022 | Spring Break | |
Mar 22, 2022 | Siddhartha Devarakonda | Development of Ras Inhibitor Therapies and Applications in Lung Cancer and Other Malignancies |
Mar 29, 2022 | Kian-Huat Lim | Role of Ras Signaling in Pancreatic Cancer |
Apr 5, 2022 | Alessandro Vindigni | DNA Replication Stress and Cancer |
Apr 12, 2022 | Priyanka Verma | DNA Repair |
Apr 26, 2022 | Luis Batista | DNA Repair |
Jun 14, 2022 | Ross L. Levine, MD Memorial Sloan Kettering Cancer Center | Deciphering and Targeting Clonal Evolution in Myeloid Malignancies |
Date | Speaker | Title |
---|---|---|
Jan 12, 2021 | Lee Ratner | Introduction |
Jan 19, 2021 | Brian Van Tine | Osteosarcoma Tumor Metabolism |
Jan 26, 2021 | David Wilson | Fanconi Anemia |
Feb 2, 2021 | Jacqueline Payton | Discoveries in Epigenomics Drive Precision Medicine Approaches in Lymphoma |
Feb 9, 2021 | Sima Bhatt | Immunotherapies for Pediatric Pre-B ALL |
Feb 16, 2021 | Grant Challen | Clonal Evolution of Blood Cancers |
Feb 23, 2021 | Charles Kaufman | Using Zebrafish Melanoma Models to Study Cancer Initiation |
Mar 2, 2021 | David Gutmann | Microenvironment Control of Pediatric Brain Tumor Formation and Growth |
Mar 9, 2021 | Luis Batista | Mutations in Telomerase and Telomere Dysfunction as Initiating Events in Pediatric Cancer Prone Syndromes |
Mar 16, 2021 | Jeffrey Bednarski | DNA Damage Signaling in B Cell Development and Leukemogenesis |
Mar 30, 2021 | Laura Schuettpelz | Inflammation and Cancer |
Apr 6, 2021 | Josh Rubin | The Biology of Sex Differences in Cancer |
Apr 13, 2021 | Jeffrey Magee | Pediatric Acute Myeloid Leukemia |
May 4, 2021 | Erin Gibson, PhD Stanford University | INVITED FACULTY LECTURE Glia-Mediated Mechanisms of Chemotherapy-Related Cognitive Impairment |
Date | Speaker | Title |
---|---|---|
Jan 14, 2020 | Kickoff Luncheon | Overview and Trainee Presentations |
Jan 21, 2020 | Lee Ratner | Introduction |
Jan 28, 2020 | Maxim Artyomov | Single Cell RNA Sequencing for Cancer |
Feb 4, 2020 | Nima Mosammaparast | DNA Repair |
Feb 11, 2020 | Jeffrey Ward | Immunotherapy |
Feb 18, 2020 | Jieya Shao | Cytoskeleton and Transcription in Breast Cancer |
Feb 25, 2020 | Angela Hirbe | Sarcoma Biology |
Mar 3, 2020 | George Souroullas | EZH2 |
Mar 10, 2020 | Spring Break – No Class | |
Mar 17, 2020 | Katherine Fuh | CANCELED Ovarian Cancer Biology |
Mar 24, 2020 | Nupam Mahajan | Tyrosine Kinases in Prostate Cancer |
Mar 31, 2020 | Ben Major | WNT Signal Transduction |
Apr 7, 2020 | Siddhartha Devarakonda | Small Cell Lung Cancer Molecular Biology |
Apr 14, 2020 | Nathan Singh | CAR T Cells |
Apr 21, 2020 | Sarah Moreland-Russell | Prevention Policy |
Date | Speaker | Title |
---|---|---|
Jan 15, 2019 | Jeff Magee, MD, PhD | Development and Pediatric Cancer |
Jan 22, 2019 | Dave Wilson, MD, PhD | Bone Marrow Failure Syndrome Associated Leukemia Predisposition |
Jan 29, 2019 | Jeff Bednarski, MD, PhD | DNA Damage and Cancer |
Feb 5, 2019 | Todd Fehniger, MD, PhD | NK Cell Immunotherapy |
Feb 12, 2019 | Todd Druley, MD, PhD | Cancer Predisposition or Minimal Residual Disease |
Feb 19, 2019 | Laura Schuettpelz, MD, PhD | Inflammation and Myeloid Malignancies |
Feb 26, 2019 | Gavin Dunn, MD, PhD | Brain Tumors and Neoantigen-Directed Immunotherapy |
Mar 5, 2019 | Brian Van Tine, MD, PhD | Tumor Metabolism |
Mar 12, 2019 | Sima Bhatt, MD | |
Mar 26, 2019 | Samantha Morris, PhD | Developmental Reprogramming |
Apr 2, 2019 | Christopher Sturgeon, PhD | In Vitro Model of Development and Malignancy |
Apr 9, 2019 | Grant Challen, PhD | Epigenetic Regulation of Stem Cell Self-Renewal and Leukemia Initiation |
Apr 23, 2019 | Trevor Pugh, PhD University of Toronto | INVITED SPEAKER Precision Medicine at Single Cell Resolution |
Date | Speaker | Title |
---|---|---|
Jan 16, 2018 | Lee Ratner, MD, PhD | Introduction |
Jan 23, 2018 | Jason Weber, PhD | Cell Cycle Inhibitors |
Jan 30, 2018 | Jason Held, PhD | Cancer Redox Biology |
Feb 6, 2018 | Neha Mehta-Shah, MD | T Cell Lymphoma Biology |
Feb 13, 2018 | Cynthia Ma, MD, PhD | PI3K/AKT |
Feb 20, 2018 | Alessandro Vindigni, PhD | Replication Stress |
Feb 27, 2018 | 1st and 2nd Year Trainees | |
Mar 6, 2018 | Sheila Stewart, PhD | Microenvironment and Cancer |
Mar 13, 2018 | Charles Kaufman, MD, PhD | Zebrafish as a Model for Cancer |
Mar 20, 2018 | Milan Chheda, MD | Cancer Stem Cells |
Mar 27, 2018 | Lee Ratner, MD, PhD | Viral Oncology |
Apr 3, 2018 | Julie Schwarz, MD, PhD | HPV and Cervical Cancer |
Apr 10, 2018 | Li Ding, PhD | Genetic Susceptibility to Cancer |
Apr 17, 2018 | Student Invited Speaker | |
Apr 24, 2018 | Student Invited Speaker |
Date | Speaker | Title |
---|---|---|
Jan 17, 2017 | David DeNardo, PhD | Tumor Microenvironment: Mediator of Disease Progression and Resistance |
Jan 24, 2017 | Grant Challen, PhD | Epigenetics in Cancer Pathogenesis |
Jan 31, 2017 | Joshua Rubin, MD, PhD | Sexual Dimorphism in Cancer Pathogenesis |
Feb 7, 2017 | Laura Schuettpelz, MD, PhD | Toll Signaling in Normal and Pathological Hematopoiesis |
Feb 14, 2017 | Chris Sturgeon, PhD | iPSC Models for the Study of Development and Cancer |
Feb 21, 2017 | Todd Druley, MD, PhD | Germline Variants and Cancer |
Feb 28, 2017 | Karen Gauvain, MD | Novel Interventions for Management of Brain Tumors |
Mar 7, 2017 | Jason Mills, MD, PhD | Pathogenesis of Gastric Metaplasia and Cancer |
Mar 21, 2017 | Jeff Bednarski, MD, PhD | DNA Repair and Oncogenesis |
Mar 28, 2017 | Jeff Magee, MD, PhD | Leukemogenesis |
Apr 4, 2017 | Brian van Tine, MD, PhD | Novel Approaches to Sarcoma Therapy |
Apr 11, 2017 | Gavin Dunn, MD, PhD | Modeling GBM |
Apr 18, 2017 | Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center | Understanding and Targeting Spliceosomal Gene Mutations in Cancer |
Date | Speaker | Title |
---|---|---|
Jan 19, 2016 | Lee Ratner, MD, PhD | Introduction of Oncology |
Jan 26, 2016 | Jason Weber, PhD | Rb and Cell Cycle Regulation |
Feb 2, 2016 | Ron Bose, MD, PhD | Cytoplasmic Signaling |
Feb 9, 2016 | Amy Barone, MD | Perspective on New Challenges in Oncology Drug Regulation in the Era of Genomics |
Feb 16, 2016 | Luis Batista, PhD | Immortalization and Cancer |
Feb 23, 2016 | Vivek Arora, MD, PhD | Nuclear Receptors in Prostate Cancer |
Mar 1, 2016 | Blair Madison, PhD | Multistep Colon Carcinogenesis |
Mar 8, 2016 | Terrence Wong, MD, PhD | p53 and Cancer |
Mar 15, 2016 | Chris Maher, PhD | Long Non-Coding RNAs in Cancer |
Mar 22, 2016 | Mark Krasnow, MD, PhD | Lung Development and Cancer |
Mar 29, 2016 | Saima Waqar, MD Len Maggi, PhD | Genomics of Lung Cancer |
Apr 5, 2016 | Jian Campian, MD, PhD Milan Chheda, MD | Neural Stem Cells and Cancer |
Apr 12, 2016 | Jackie Payton, MD, PhD | Epigenomic Regulation of Cancer |
Apr 19, 2016 | Casey Wilson Postdoc Research Scholar Ted Keppel Postdoc Research Scholar Bhavna Murali DBBS Pre Doc Trainee | |
Jun 14, 2016 | Judith Campisi, PhD Buck Institute for Research on Aging | Cancer and Aging: Rival Demons? |
Date | Speaker | Title |
---|---|---|
Jan 20, 2015 | Joshua Rubin | Sexual Dimorphism in Cancer Pathogenesis |
Jan 27, 2015 | Kimberly Johnson | Harnessing Epidemiology to Study Cancer: Focus on NF1 |
Feb 3, 2015 | Luis Batista | Telomere Dysfunction in Cancer; IPSCs as a Model System |
Feb 10, 2015 | David DeNardo | Tumor Stem-Like Cells and Immune Responses |
Feb 17, 2015 | Deb Novack | Molecular Basis of Cancer Metastasis |
Feb 24, 2015 | Jason Weber | Tumor Suppressors and the Cell Cycle |
Mar 3, 2015 | Grant Challen | Role of Epigenetics in Cancer Pathogenesis |
Mar 17, 2015 | Sergej Djuranovic | Non-Synonymous ≠ Innocent: Somatic Mutations and Translation in Cancer Cells |
Mar 24, 2015 | Jeff Bednarski | Breaking Bad: DNA Repair and Oncogenesis |
Mar 31, 2015 | Jeff Magee | Stem Cells and Leukemogenesis |
Apr 7, 2015 | Todd Druley | How Rare Germline DNA Variants Conspire to Trigger Childhood Cancer |
Apr 14, 2015 | Katherine Fuh | Modeling Ovarian Carcinoma |
Apr 21, 2015 | Brian Van Tine | Novel Approaches to Sarcoma Therapy |
Date | Speaker | Title |
---|---|---|
Jan 28, 2014 | Ravi Salgia University of Chicago | Novel Targets in Lung Cancer |
Feb 4, 2014 | Andrey Shaw | BRAF |
Feb 11, 2014 | Lukas Wartman | Personalized Medicine |
Feb 18, 2014 | Rizwan Romee | NK Therapy |
Feb 25, 2014 | Charles Rudin Memorial Sloan Kettering | Lung Treatments |
Mar 4, 2014 | Obi Griffith | Druggable Genome |
Mar 11, 2014 | Barry Sleckman | DNA Repair |
Mar 18, 2014 | Ron Bose | HER2 |
Mar 25, 2014 | Frederick Appelbaum Fred Hutchinson | AML |
Apr 1, 2014 | Kian-Huat Lim | Oncogenic Ras Signaling in Human Cancer |
Apr 8, 2014 | Geoffrey Uy | Bispecific Antibodies |
Apr 15, 2014 | Erika Pearce | T Cell Metabolism in Cancer |
Apr 22, 2014 | Yibin Kang Princeton | How Cancer Cells Acquire Metastatic Traits |